Today: 26 April 2026
CapitaLand Investment share price: What 9CI holders watch after director filings, ahead of Feb 11 results
1 February 2026
1 min read

CapitaLand Investment share price: What 9CI holders watch after director filings, ahead of Feb 11 results

Singapore, Feb 1, 2026, 15:06 SGT — Market closed.

  • CapitaLand Investment (SGX:9CI) ended the day unchanged, closing at S$3.08.
  • Filings late in the week revealed shifts in director interests related to treasury share transfers.
  • CapitaLand Ascott Trust, a major managed trust, released its FY2025 distribution figures as earnings season kicks off.

CapitaLand Investment shares (SGX:9CI) closed flat on Friday at S$3.08, fluctuating within a range of S$3.05 to S$3.10. The stock traded roughly 13 million shares.

As the Singapore market remains closed for the weekend, attention turns to the upcoming wave of full-year results and distribution announcements from CapitaLand-managed listed vehicles, followed by the manager’s own earnings. This stretch could shift expectations around fee income and capital recycling, even if the parent company’s stock stays muted.

Friday brought a wave of board-related disclosures. On their own, these filings rarely shift a stock, but they can stir up some noise when liquidity is light.

David Su Tuong Sing disclosed buying 25,009 shares on Jan. 28 at S$2.543 each, acquiring them through a transfer of treasury shares. This raised his direct stake from 55,241 to 80,250 shares. Treasury shares refer to stock a company holds post-buyback and can be allocated for share-based payments without issuing fresh shares.

CapitaLand Ascott Trust, managed by subsidiaries of CapitaLand Investment, reported on Thursday. The trust held its full-year distribution per stapled security (DPS) steady at 6.10 Singapore cents, even as income available for distribution climbed 11% to S$256.7 million. Serena Teo noted, “We are progressing towards our medium-term portfolio allocation of 25%–30% in the living sector.” Lui Chong Chee added, “Looking ahead, we are focused on delivering sustainable growth and long-term value for our Stapled Securityholders.” The trust confirmed that stapled securityholders will receive their second-half payout on Feb. 27. SGX Links

CapitaLand Investment outlined a busy schedule of earnings announcements in a Singapore Exchange notice, with results from its listed funds rolling out before its FY2025 report on Feb. 11, ahead of market open. The lineup starts with CapitaLand India Trust on Feb. 2, followed by CapitaLand China Trust and CapitaLand Ascendas REIT on Feb. 5, and then CapitaLand Integrated Commercial Trust on Feb. 6.

The filing noted that CapitaLand Investment plans a results briefing at 9 a.m. on the day it reports earnings, open to invited analysts and media. There will be a “live” webcast available. SGX Links

CapitaLand Investment manages real assets and collects fees from overseeing listed property trusts and private funds. Morningstar reports its total assets under management stood at SGD 117 billion as of June 30, 2025.

The downside risk is straightforward. If upcoming results reveal weaker asset values, sluggish asset sales, or faltering performance in key portfolios, fee forecasts could quickly be revised downward — and real estate managers often react sharply to that.

Next up, all eyes will be on Monday’s CapitaLand India Trust figures, followed by CapitaLand Investment’s FY2025 results scheduled for Feb. 11.

Stock Market Today

  • Thermo Fisher Scientific (TMO) Shows Undervaluation After Recent Price Drop
    April 26, 2026, 7:36 AM EDT. Thermo Fisher Scientific's shares have declined 10.8% over the past week and 20.7% year-to-date, yet the stock still delivered an 11.1% return over the last year. Analysts using a Discounted Cash Flow (DCF) model estimate the intrinsic value at $606.38 per share, suggesting the current price of $469.71 represents a 22.5% discount. This implies undervaluation based on projected free cash flows rising to $11.95 billion by 2030. The mixed short-term returns reflect shifting investor sentiment in the healthcare tools sector, but the company's core operations remain steady. Valuation metrics, including the DCF and price-to-earnings ratios, underline potential value in the stock amid recent market weaknesses.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 26.04.2026

26 April 2026
LIVEMarkets rolling coverageStarted: April 26, 2026, 12:00 AM EDTUpdated: April 26, 2026, 7:38 AM EDT May 15 Threat to Trump's Bull Market Surpassing Tariffs April 26, 2026, 7:38 AM EDT. Wall Street has thrived under President Donald Trump, with the Dow Jones, S&P 500, and Nasdaq Composite delivering strong annualized returns. However, market watchers are shifting focus from Trump's tariff policies-which have faced legal challenges and mixed effects-to an even greater threat slated to emerge on May 15. Tariffs imposed to encourage domestic manufacturing and protect U.S. firms showed adverse impacts on employment, productivity, and corporate profits, according to a
Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
Global Unichip (3443) stock slips on margin squeeze; next catalyst is Feb. 10 revenue data
Previous Story

Global Unichip (3443) stock slips on margin squeeze; next catalyst is Feb. 10 revenue data

Genting Singapore share price: What to watch after the RWS chair change and fresh broker calls
Next Story

Genting Singapore share price: What to watch after the RWS chair change and fresh broker calls

Go toTop